NEW YORK–(BUSINESS WIRE)–July 28, 2022–
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Enochian BioSciences, Inc. (NASDAQ: ENOB) securities between September 24, 2020 and May 31, 2022, both dates inclusive (the “Class Period”). If you wish to act as lead plaintiff, you must move the Court no later than September 26, 2022.
SO WHAT: If you purchased Enochian BioSciences securities during the Class Period, you may be entitled to compensation without payment of any disbursements or fees through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you wish to act as lead plaintiff, you must move the Court no later than September 26, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.
WHY THE ROSEN LAW: We encourage investors to select qualified attorneys with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Serhat Gumrukçu, the inventor and co-founder of Enochian BioSciences, n was not a licensed physician and had no verifiable credentials beyond high school; (2) as a result, the scientific and technological underpinnings of Enochian BioSciences’ portfolio of products, allegedly invented by Gumrukçu, were questionable at best; (3) as a result, the defendants had significantly overestimated the commercial prospects of the Company’s product portfolio; (4) senior management of Enochian BioSciences knew that Gumrukçu had a criminal history that included fraud; (5) Accordingly, Enochian BioSciences’ reliance on Gumrukçu, as well as its consulting and licensing agreements with G-Tech Bio, LLC and Seraph Research Institute (“SRI”), both controlled by Gumrukçu, exposed the Company to an increased risk of reputational and financial damage, as well as a threat to the integrity of the Company’s scientific findings; and (6) therefore, the Company’s public statements were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims investors suffered damages.
To join the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.
No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent party member and do nothing at this point. An investor’s ability to participate in any potential future recovery does not depend on their status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertisement. Previous results do not guarantee a similar result.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220728006060/en/
CONTACT: Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: CLASS ACTION PROFESSIONAL SERVICES LEGAL
SOURCE: The Rosen Law Firm, Pennsylvania
Copyright BusinessWire 2022.
PUBLISHED: 7/28/2022 5:06 PM / DISK: 7/28/2022 5:06 PM
Copyright BusinessWire 2022.